Journals / İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi / 2022 / Sayı: 17

Effect of SORT1 rs599839 Polymorphism on Lipid Profiles: A Single City Experience

SORT1 rs599839 Polimorfizminin Lipit Profillerine Olan Etkisi: Tek Şehir Deneyimi

Pages
369–380
Publication Date
2022-08-29
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Our aim in this study; To determine whether the SORT1 rs599839 gene variants have an effect on CHD development and lipid parameters in the Giresun province of Turkey.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The SORT1 gene encoding Sortilin-1 (SORT1), a receptor of the VPS10p family, is localized at 1p13.3.
📊
Key Findings & Data:SORT1 has been associated with the risk of developing coronary heart disease (CHD) in genome wide association studies (GWAS) due to its association with hepatic lipid metabolism and low-density lipoprotein-cholesterol (LDL-C) levels.
💡
Conclusion & Impact:Our aim in this study; To determine whether the SORT1 rs599839 gene variants have an effect on CHD development and lipid parameters in the Giresun province of Turkey.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:SORT1 · Sortilin1 · polimorfizm

Abstract

Aim: The SORT1 gene encoding Sortilin-1 (SORT1), a receptor of the VPS10p family, is localized at 1p13.3. SORT1 has been associated with the risk of developing coronary heart disease (CHD) in genome wide association studies (GWAS) due to its association with hepatic lipid metabolism and low-density lipoprotein-cholesterol (LDL-C) levels. Various variations on the SORT1 gene region cause different effects on lipid profiles. Our aim in this study; To determine whether the SORT1 rs599839 gene variants have an effect on CHD development and lipid parameters in the Giresun province of Turkey.

Özet

Amaç: VPS10p ailesinin bir reseptörü olan Sortilin-1(SORT1)’i kodlayan SORT1 geni 1p13.3’de lokalizedir. SORT1 genom çapında ilişkilendirme çalışmalarında (GWAS) hepatik lipit metabolizması ve düşük dansiteli lipoprotein-kolesterol (LDL-K) seviyeleri ile olan ilişkisinden dolayı koroner kalp hastalığı (KKH) oluşturma riski ile ilişkilendirilmiştir. SORT1 gen bölgesi üzerindeki çeşitli varyasyonlar lipit profilleri üzerinde farklı etkilere neden olmaktadır. Bizim bu çalışmadaki amacımız; Giresun ilinde SORT1 rs599839 gen varyantlarının KKH gelişimi ve lipit parametreleri üzerine bir etkisinin olup olmadığını belirlemektir.

🔖

Cite This Article

AKADAM-TEKER, A. B., TEKER, E. (2022). Effect of SORT1 rs599839 Polymorphism on Lipid Profiles: A Single City Experience. İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi, Sayı: 17, 369–380. https://ajindex.com/articles/675865

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Mozaffarian D, Benjamin EJ, Alan SG, et al. Heart disease and stroke statistics-2016 update: A report from the American Heart Association. Circulation. 2016;133:e38–60. Jia-Yin D, Meng-Lu D, Zong-Xin Z. ENPP1 K121Q (rs1044498C>A) genetic polymorphism confers a high risk of susceptibility to coronary heart disease. A PRISMA-Compliant Article Medicine. 2018;97:27(e11236). Tabas I, Williams KJ, Boren J. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: Update and therapeutic implications. Circulation. 2007;116:832-844.
  2. Lıttle PJ, Chaıt A, Bobık A. Cellular and cytokinebased inflammatory processes as novel therapeutic targets for the prevention and treatment of atherosclerosis. Pharmacol Ther. 2011;131:255-268.
  3. Kjolby M, Andersen OM, Breiderhoff T, et al. SORT1, encoded by the cardiovascular risk locus 1p13.3, is a regulator of hepatic lipoprotein export. Cell Metab. 2010;12:213–223.
  4. Dube JB, Johansen CT, Hegele RA. Sortilin: An unusual suspect in cholesterol metabolism: From GWAS identification to in vivo biochemical analyses, sortilin has been identified as a novel mediator of human lipoprotein metabolism. BioEssays. 2011;33:430–437.
  5. Strong A, Rader DJ. Sortilin as a regulator of lipoprotein metabolism. Curr Atheroscler Rep. 2012;14:211–218.
  6. Ogawa K, Ueno T, Iwasaki T, et al. Soluble sortilin is released by activated platelets and its circulating levels are associated with cardiovascular risk factors. Atherosclerosis. 2016;249:110–115.
  7. Anbo G, Francisco SC, Xi C, et al. Implications of Sortilin in Lipid Metabolism and Lipid Disorder Diseases. Dna and cell bıo. 2017;36:1050–1061.
  8. Musunuru K, Strong A, Frank-Kamenetsky M, et al. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature. 2010;466:714-719.
  9. Kjolby M, Nielsen MS, Petersen CM. Sortilin, encoded by the cardiovascular risk gene SORT1, and its suggested functions in cardiovascular disease. Curr Atheroscler Rep. 2015;17: 496–505.
  10. Patel KM, Strong A, Tohyama J, et al. Macrophage sortilin promotes LDL uptake, foam cell formation, and atherosclerosis. Circ Res. 2015;116:789–796.
  11. Guo J, Luo YX, Tao LX, Guo X.H. Association between 1p13.3 genomic markers and coronary artery disease: a meta-analysis involving patients and controls. GMR. 2015;14:9092–9102.
  12. Sparks CE, Sparks RP, Sparks JD. The enigmatic role of sortilin in lipoprotein metabolism. Curr Opin Lipidol. 2015;26:598–600. World Medical Association World Medical Association Declaration of Helsin